Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene)

Diabetes

Volumn 49, Issue 11, 2000, Pages 1856-1864

  Clocquet, Astrid R ^a   Egan, Josephine M ^c   Stoffers, Doris A ^b   Muller, Denis C ^c   Wideman, Laurie ^d   Chin, Gail A ^a   Clarke, William L ^d   Hanks, John B ^d   Habener, Joel F ^b   Elahi, Dariush ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN PROMOTER FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IPF 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; JUVENILE DIABETES MELLITUS; MALE; MATURITY ONSET DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PEDIGREE; PRIORITY JOURNAL;

EID: 0033755186     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.11.1856     Document Type: Article

References (37)

1. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people
2. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
3. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
4. Early-onset type 2 diabetes mellitus (MODY4) linked to IPF- 1
5. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY
6. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus
7. Linkage of type 2 diabetes to the glucokinase gene
8. Pancreatic agenesis attribute to a single nucleotide deletion in the human IPF- 1 coding region
9. Insulin-promoter-factor 1 is required for pancreas development in mice
10. Glucose modulates the binding activity of the β-cell transcription factor IUF-1 in a phosphorylation-dependent manner
11. The p38 reactivating kinase mitogen-activated protein kinase cascade mediates activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells
12. Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF 1 acting through CT boxes
13. Glucose modulates the binding of an islet-specific factor to a conserved sequences within the rat I and the human insulin promoters
14. Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells
15. Regulatory factor linked to late-onset diabetes
16. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX- 1 homeobox facto
17. Involvement of the homeodomain-containing transcription factor PDX- 1 in islet amyloid polypeptide gene transcription
18. Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic β-cells
19. PDX-1 induces insulin and glucokinase gene expressions in a TC1 clone 6 cells in the presence of β-cellulin
20. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
21. Missense mutations in the insulin promoter factor 1 (IPF-1) gene predispose to type 2 diabetes
22. The gene MAPK8IP1, encoding islet-brain- 1, is a candidate for type 2 diabetes
23. The influence of anatomical boundaries, age, and sex on the assessment of abdominal visceral fat
24. In praise of the hyperglycemic clamp
25. Insulinotropic hormone glucagon like peptide-1 (7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia
26. The effect of recombinant human IGF- 1 on glucose and leucine kinetics in man
27. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis
28. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves
29. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon like peptide-1 (7-37) in normal and diabetic subjects
30. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1α gene
31. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutation in the diabetes susceptibility gene MODY3 on chromosome 12
32. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree
33. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY 1 gene on chromosome 20
34. Primary pancreatic β-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
35. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
36. Characterization of the MODY3 phenotype: Early-onset diabetes caused by an insulin secretion defect
37. Assessment of insulin sensitivity in glucokinase-deficient subjects